Açıkgöz, E. Et Al. 2022. “Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells. International Immunopharmacology , vol.107 .

Açıkgöz, E., Duzagac, F., Guven, U., Yigitturk, G., Kose, T., & Oktem, G., (2022). “Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells. International Immunopharmacology , vol.107.

Açıkgöz, Eda Et Al. "“Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells," International Immunopharmacology , vol.107, 2022

Açıkgöz, Eda Et Al. "“Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells." International Immunopharmacology , vol.107, 2022

Açıkgöz, E. Et Al. (2022) . "“Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells." International Immunopharmacology , vol.107.

@article{article, author={Eda Açıkgöz Et Al. }, title={“Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells}, journal={International Immunopharmacology}, year=2022}